Synthetic Biodesign, LLC

Porvo, UT · Biotech · Private

A natural products-based drug discovery platform using synthetic biology to generate novel bioactive molecules for high-throughput screening of Huntington's disease therapeutics.

syntheticbiodesign.com →
Grants
$365K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Development of a Natural Products-Based High Throughput Screen: Identification of Correctors of Cystic Fibrosis Misfolding Mutants$149,964
Federal grantDepartment of Health and Human Services · Phase I · Therapeutics for Huntington's Disease$214,977
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2059Angitia Biopharmaceuticals——
2060RADTRAN LLC——
2061BIOAXONE BIOSCIENCES, INC.——
2062Synthetic Biodesign, LLC——
2063Silverpeutics Inc.—$12M
2064General Probiotics Inc——
2065PNEUMOTACTIX, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.